eli lilly retatrutide press release 2024 2025 Lilly, with new data, to seek FDA approval of obesity drug Eli Lilly posts mixed quarter

Management flagged that 4Q25 EBITDA will step down sequentially as marketing ramps into peak season, seasonal staffing costs hit, and an accounting change pulls some advertising expense forward

Oceania Researchers employ a variety of methodologies including in vitro studies, animal models, and clinical trials to examine the peptides biochemical interactions and physiological effects

Some forms of magnesium are effective antacids 2

The oral bioavailability of Farxiga is 78%

Canadian Press health coverage receives support through a partnership with the Canadian Medical Association

Symptomatic magnesium deficiency remains relatively uncommon, but awareness of potential risk factors allows for appropriate clinical vigilance, particularly in patients with persistent gastrointestinal symptoms or those on multiple medications affecting mineral balance